Trials & R&D · first seen 1h ago, updated 1h ago
2026 IMS | Updated FUMANBA-1 Analysis of IASO Bio's FUCASO Reveals That In Vivo Durable Persistence of CAR-T cells Is Associated with Sustained MRD Negativity and Delayed Disease Progression
At 2026 IMS: Updated FUMANBA-1 Data from IASO Bio's Equecabtagene Autoleucel (Fucaso) Demonstrate In Vivo Durable Persistence of CAR-T Cells Associated with Sustained MRD-Negativity and Delayed Disease Progression — Retrospective analysis o…
Summary from PR Newswire - Clinical Trials.